Author pages are created from data sourced from our academic publisher partnerships and public sources.
Relationship of Plasma Galectin-3 to Renal Function in Patients With Heart Failure: Effects of Clinical Status, Pathophysiology of Heart Failure, and Presence or Absence of Heart Failure
- D. Gopal, M. Kommineni, +8 authors W. Colucci
- Journal of the American Heart Association
- 1 October 2012
Background Galectin-3 (GAL-3), a β-galactoside–binding protein, is a new clinical biomarker believed to reflect cardiac remodeling/fibrosis in patients with heart failure (HF). Plasma GAL-3 is… Expand
Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
- A. Biolo, N. Clausell, +4 authors L. Rohde
- The American journal of cardiology
- 15 September 2008
Beta1-adrenergic receptor polymorphisms have been implicated with inconsistent results in the pathogenesis, clinical presentation, and prognosis of patients with heart failure (HF). The impact of 2… Expand
Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial.
- G. Aliti, E. Rabelo, N. Clausell, L. Rohde, A. Biolo, Luís Beck-da-Silva
- JAMA internal medicine
- 24 June 2013
IMPORTANCE The benefits of fluid and sodium restriction in patients hospitalized with acute decompensated heart failure (ADHF) are unclear. OBJECTIVE To compare the effects of a fluid-restricted… Expand
Chagas cardiomyopathy--where do we stand after a hundred years?
A hundred years from its description, Chagas cardiomyopathy remains a challenging disease. Although successful vector-control strategies have decreased the incidence of Chagas disease in several… Expand
Ventricular dysfunction and dilation in severe sepsis and septic shock: relation to endothelial function and mortality.
PURPOSE The aim of this study was to evaluate echocardiography-based indices of myocardial function and markers of vascular inflammation and endothelial dysfunction in the early phases of severe… Expand
A nurse‐based strategy reduces heart failure morbidity in patients admitted for acute decompensated heart failure in Brazil: the HELEN‐II clinical trial
- E. N. de Souza, L. Rohde, +5 authors E. Rabelo-Silva
- European journal of heart failure
- 1 September 2014
Home‐based interventions for heart failure (HF) patients might be particularly effective in middle‐income countries, where social, cultural, and economic constraints limit the effectiveness of HF… Expand
Episodes of Acute Heart Failure Syndrome Are Associated With Increased Levels of Troponin and Extracellular Matrix Markers
Background—Increased myocyte loss and extracellular matrix (ECM) turnover are central mechanisms that contribute to pathological myocardial remodeling in chronic heart failure (HF). We tested the… Expand
A prospective, comparative study on the early effects of local and remote radiation therapy on carotid intima-media thickness and vascular cellular adhesion molecule-1 in patients with head and neck…
- M. N. Pereira Lima, A. Biolo, M. Foppa, P. R. da Rosa, L. E. Rohde, N. Clausell
- Radiotherapy and oncology : journal of the…
- 1 December 2011
BACKGROUND AND PURPOSE To investigate early vascular changes related to carotid atherosclerotic injury post-radiation therapy (RT), we studied carotid intima-media thickness (IMT) and vascular… Expand
Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors
- E. Baumgart, M. Cohen, +8 authors I. Summerhayes
- Medicine, Biology
- Clinical Cancer Research
- 15 March 2007
Purpose: Epithelial to mesenchymal transition (EMT) is reportedly an important transition in cancer progression in which the underlying cellular changes have been identified mainly using in vitro… Expand
Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia.
OBJECTIVE Endothelial markers endothelin 1 (ET-1) and von Willebrand factor (vWF) were assessed in patients with type 2 diabetes and dyslipidemia and in patients with hypercholesterolemia. RESEARCH… Expand